by Team NovaGray | Mar 24, 2022 | Innovations
SHORT VERSION A blood sample-based test that assesses the rate of lymphocyte (white blood cell) death after irradiation is currently available in clinical routine. This test assesses the probability of developing late complications after breast or prostate...
by Team NovaGray | Mar 24, 2022 | Radiosensivity
SHORT VERSION Knowing each patient’s radiosensitivity level before treatment initiation allows: in the absence of risk, reassuring the patient about radiotherapy; in the presence of a risk of hypersensitivity, adapting the treatment and follow-up to minimize the...
by Team NovaGray | Mar 24, 2022 | Radiotherapy-Prostate cancer
SHORT VERSION When used as first treatment option, radiation therapy can be performed using two regimens: normo-fractionated radiotherapy: 38 to 40 sessions, one session per day from Monday to Friday, over 8 weeks hypo-fractionated radiotherapy: 20 sessions, over 4...
by Team NovaGray | Mar 24, 2022 | Before and during radiotherapy
SHORT VERSION Late complications of radiation therapy appear between 3 months and up to 3 years after the treatment end and they are irreversible. The occurrence of these complications is very difficult to predict. It is estimated that only 5 to 10% of all patients...
by Team NovaGray | Mar 24, 2022 | After radiotherapy
It should be noted that there is no consensus on preventive or curative treatments for dermatitis caused by radiotherapy. However, some hygiene rules are essential to limit the severity of skin toxicities. It is important to avoid wearing tight clothing in contact...
